VICENTE
ESTRADA PÉREZ
Profesor asociado de Ciencias de la Salud
Hospital General de Granollers
Barcelona, EspañaHospital General de Granollers-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Infectious Diseases and Therapy, Vol. 11, Núm. 3, pp. 1177-1192
2021
-
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
PloS one, Vol. 16, Núm. 4, pp. e0249515
-
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
HIV Research and Clinical Practice, Vol. 22, Núm. 3, pp. 78-85
2008
-
Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease
HIV Clinical Trials, Vol. 9, Núm. 2, pp. 83-90
2006
-
Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 2, pp. 96-117